MedPath

The effect of melatonin on endometrial histology in patients with disordered simple hyperplasia.

Phase 3
Recruiting
Conditions
Endometrial hyperplasia.
Endometrial hyperplasia
N85.0
Registration Number
IRCT20120922010901N10
Lead Sponsor
Vice chancellor for Research,Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

Age of 38 to 55 years
Women with abnormal uterine bleeding and proliferative endometrium with irregular glands
Willingness to participate in the study
BMI between 18.5 and 29.99

Exclusion Criteria

Atypical hyperplasia and endometrial cancer diagnosis
History of hormone therapy in the last 3 months
Not consent to participate in the study
Diabetes
History of depression and use of antidepressants
Coagulation disorders
Hypertension
Seizures and the use of antiepileptic drugs
Having autoimmune diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Histologic types of endometrium. Timepoint: Three months after the first dose of the drug. Method of measurement: Microscopic examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath